Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.4.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.181NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.6.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.37NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FZ.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FY.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.497NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EN.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.30 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.85 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.6.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.21NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FK.1.3.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBFNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.11.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBF.7.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FY.5.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FP.2.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.2.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.2.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JW.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JL.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.571NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.55 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XAMNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.239NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.574NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.355NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GA.7.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.403NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.27NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.30NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HH.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KN.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.43.1 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.332NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JB.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.86.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JW.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.2.3.18NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBC.1.6.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.39NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.141NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.591NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.468NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.131 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.586NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used